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Abstract 13 
The quite recent discovery that parasites release extracellular vesicles (EVs) that can transfer 14 
a range of effector molecules to host cells has made us re-think our understanding of the host-15 
parasite interface. In this opinion article we will consider how recent proteomics and 16 
transcriptomics studies, together with ultrastructural observations, suggest that more than one 17 
mechanism of EV biogenesis can occur in helminths. We propose that distinct EV sub-types 18 
have roles in immune-modulation and repair of drug-induced damage, and put forward the 19 
case for targeting EV biogenesis pathways to achieve parasite control. In doing so we raise a 20 
number of outstanding research questions that must be addressed before this can happen.  21 
22 
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Molecular communication at the host-parasite interface  23 
The persistence of helminth parasites in their mammalian hosts has been ascribed to their 24 
striking ability to manipulate host immune responses.  Many helminths are obligate blood 25 
feeders and can deliver secreted molecules into the bloodstream where they exert an 26 
immunosuppressive activity on the host immune system [1]. Other molecules are secreted 27 
from the gut, excretory pores and surface cuticle/tegument into the local microenvironment, 28 
often the host intestine [2-4].  For many years the paucity of material made these secretions 29 
extremely difficult to analyse but the application of mass spectrometry-based proteomics 30 
techniques has allowed a detailed understanding of the type and abundance of the various 31 
proteins present in soluble helminth secretions (reviewed in [5]).  However, until quite 32 
recently the contribution of extracellular vesicles (EVs; see glossary) to helminth secretomes 33 
has been overlooked.   34 
EVs are small membrane-bound structures that are shed by most cell types. Although 35 
once considered to act solely as a cellular waste disposal system [6], EVs are now recognised 36 
as important mediators of cell-cell communication by transferring a range of effector 37 
molecules including proteins, lipids, mRNA, microRNA and other non-coding RNA species.  38 
Variously described as exosomes or microvesicles (MVs) depending on their composition, 39 
size and mode of biogenesis (see below), EVs not only perform a variety of roles in the 40 
maintenance of normal physiology but also participate in pathological settings, notably in 41 
tumour progression [7-9]. A growing number of studies have also shown that parasite-derived 42 
EVs play an important role during infection and pathogenesis [10]. Although most of these 43 
studies have focused on profiling the molecular cargo packaged into parasite EVs, they have 44 
provided a valuable first insight into the putative mechanism(s) used by parasites for EV 45 
biogenesis and release. Here, we will briefly summarise the current understanding of EV 46 
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biogenesis in mammalian cells and examine the ultrastructural and biochemical evidence for 47 
EV biogenesis and export mechanisms used by helminth parasites.   48 
 49 
EV biogenesis pathways in mammalian cells 50 
There are two major subtypes of EVs that are actively released by viable cells: exosomes and 51 
microvesicles (MVs). Exosomes are typically 30-100 nm in diameter and originate from the 52 
endosomal pathway of eukaryotic cells. The process starts with inward budding of the late 53 
endosome membrane which forms multivesicular bodies (MVBs) containing a number of 54 
intraluminal vesicles (ILVs). The ILVs are then secreted from the cell surface (as exosomes) 55 
following fusion of the MVB with the plasma membrane. The principal machinery that drives 56 
this process is the endosomal sorting complex required for transport (ESCRT). ESCRT-0, 57 
-I, and -II complexes cluster ubiquitinated proteins to the endosomal membrane, whilst 58 
ESCRT-III forms polymeric filaments that result in the invagination of the membrane, 59 
forming the ILV [11-14]. The final abscission of the budding ILVs into the MVB lumen 60 
requires the AAA-ATPase VPS4 [15]. However, ESCRT-independent pathways have been 61 
reported that centre around several members of the tetraspanin family [16] or that require the 62 
generation of ceramide by neutral sphingomyelinase [17]. In this respect, Colombo et al. [18] 63 
proposed four molecular machineries involved in ILV formation: (1) the ESCRT pathway; 64 
(2) the lipid pathway primarily involving the lipid hydrolases neutral sphingomyelinase and 65 
phospholipase D2; (3) the tetraspanins route where CD63 plays a principal role; and (4) a 66 
hybrid mechanism combining elements of all the former machineries together. The 67 
subsequent fusion of MVBs with the plasma membrane is dependent on small GTPases 68 
including Ral-1, Rab8b, Rab11, Rab27a and Rab27b and the Rab effectors otoferlin and 69 
synaptotagmin-like protein [19-22].  70 
4 
 
Microvesicles (MVs) are larger than exosomes (diameter 100-1000 nm) and originate 71 
by direct budding from the plasma membrane in response to a variety of external stimuli 72 
which generally lead to elevated intracellular Ca2+ levels and cytoskeleton-driven membrane 73 
remodelling [23,24]. This Ca2+ signalling cascade activates scramblase that is responsible for 74 
the translocation of phosphatidylserine to the outer leaflet of the plasma membrane. The 75 
resulting membrane asymmetry is thought to drive localised curvature of the plasma 76 
membrane. MV budding is driven further by the rearrangement of the actin cytoskeleton 77 
conducted by calpain [25]. Many studies suggest that small GTPases, such as ARF6, play a 78 
key role in MV formation by indirectly activating proteases in response to the activation of 79 
the extracellular signal-regulated kinase (ERK) [24]. Although the final abscission 80 
mechanism of the MV is not fully understood, the late ESCRT component VPS4 is likely to 81 
be involved in the same way that it drives abscission of the budding ILVs into the MVB 82 
lumen during exosome biogenesis [26]. Whilst both exosomes and MVs can deliver cargo to 83 
target cells, and are released by viable cells in an energy-dependent manner, most cells 84 
constitutively produce exosomes whilst MVs are generally released in response to specific 85 
signals [27].  86 
 87 
EVs as potential targets for anti-parasite therapy  88 
Several studies have described the modulatory effects of parasite-derived EVs on the host 89 
immune system [28-30] or the pathological effects on host cells [31]. Indeed, the role of 90 
helminth EVs as vehicles for transfer of small RNAs (especially miRNA) to host cells has 91 
been extensively documented in the last few years [28,32-35] suggesting a new mechanism 92 
used by parasites to influence host cell function at a molecular level. Targeting key regulators 93 
of EV biogenesis (including sphingomyelinase, ESCRT components and Rab GTPases) using 94 
chemical inhibitors or RNAi has been shown to significantly reduce the number of EVs 95 
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released by mammalian cells (Table 1). Indeed, suppressing EV production to inhibit their 96 
effect in disease is an emerging therapeutic strategy that has yielded impressive results, 97 
notably in cancer therapy (reviewed in [8]). In the same vein, parasite EV biogenesis 98 
pathways might be an attractive therapeutic target if selective inhibitors could be identified. 99 
Disrupting the packaging, biogenesis and/or release of parasite EVs would prevent the 100 
delivery of a plethora of protein or small RNA immunomodulators to host cells; thus, 101 
allowing the host to mount an effective immune response against the parasite. Silencing of a 102 
range of orthologues of molecules that function at different stages of EV biogenesis pathways 103 
in mammalians cells led to varied aberrant phenotypes in Caenorhabditis elegans (Table 1). 104 
Whilst the direct impact on EV production was not assessed for all of these targets, MVBs 105 
accumulated below the cuticle layer (and did not fuse with the plasma membrane) when the 106 
vATPase V0 subunit and GTPase Ral-1 were mutated or silenced [22,45]. The challenge now 107 
is to determine how silencing EV biogenesis components in parasitic helminths impacts their 108 
ability to establish infection and avoid the host immune response. For instance, silencing 109 
syntenin (involved in ILV formation and cargo sorting) had no effect on the ability of 110 
schistosomulae and adult schistosomes to survive in vitro culture however their ability to 111 
persist in mammalian hosts was not investigated [46].  112 
 113 
Exosome biogenesis in helminths – insights from Fasciola hepatica 114 
To date, much of our understanding of EV biogenesis in helminths comes from studies on the 115 
liver fluke, Fasciola hepatica. A detailed proteomics analysis of its secretome showed that F. 116 
hepatica releases at least two major sub-populations of EVs that differ according to size, 117 
cargo molecules and probable site of origin [47]. The sub-population of smaller EVs (30-100 118 
nm diameter) contain a number of well-known exosomal markers, also identified in other 119 
helminth parasites, such as Hsp70, ALIX, tetraspanin CD63 and several Rab GTPases 120 
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suggesting that Fasciola secretes bona fide exosomes. In support of this, mass spectrometry 121 
data strongly suggests an endosomal origin of the smaller secreted vesicles; up to ten proteins 122 
from the ESCRT pathway were found associated with the vesicles. These included members 123 
of the ESCRT-III complex and the Vps4 ATPase responsible for ILV budding and abscission 124 
respectively as well as the ESCRT-associated proteins ALIX and syntenin [47].  125 
Compared with the plasma membrane, exosomal membranes are enriched in certain 126 
phospholipids as well as cholesterol and ceramide.  They also contain numerous lipid-binding 127 
proteins such as annexins that are organized in specialised lipid rafts called tetraspanin-128 
enriched microdomains (TEMs). Lipid hydrolases (typically sphingomyelinases and 129 
phospholipase B) and cholesterol transporters are also characteristic features of exosome 130 
membranes [9]. TEMs are believed to have roles in both exosome biogenesis and the sorting 131 
of cargo by promoting specific compartmentalisation of proteins and receptor molecules into 132 
the budding ILVs [16]. According to the mass spectrometry data, the F. hepatica exosomes 133 
contain all the necessary proteins to organise the membrane into TEMs (including several 134 
members of the tetraspanin and annexin families, an acid sphingomyelinase, a phospholipase 135 
B2-like enzyme as well as the cholesterol transporters Niemann Pick C1 and C2 proteins; 136 
[47]). Due to their biophysical properties, TEMs have also been defined as detergent-resistant 137 
microdomains [48]. Such organization would confer a high rigidity to F. hepatica EV 138 
membranes (and presumably to those from other helminths) at neutral pH that would help to 139 
preserve their structural integrity, and persistence, in host bile and other biological fluids.  140 
Indeed, exosome-like vesicles from the nematode parasite Brugia malayi have been detected 141 
in host circulatory blood, suggesting that they may act at effector sites well beyond that of the 142 
local host microenvironment [30]. Recently it was shown that exosome membranes from the 143 
nematode parasite Heligmosomoides polygyrus are enriched with plasmalogens and other 144 
specialised ether phospholipids that confer greater vesicle rigidity compared with host-145 
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derived exosomes [49].  Thus, is it likely that the unique lipid and protein composition of 146 
parasite EV membranes has evolved to confer the greatest protection possible to the cargo 147 
packaged within the vesicle lumen.  148 
 149 
Ultrastructural evidence for EV biogenesis in helminths 150 
Whilst much of the biochemical and proteomics data to date supports an endosomal origin for 151 
helminth exosomes, further ultrastructural studies are required to confirm this. Exosome-like 152 
vesicles have been described associated with the lining of the gut in Schistosoma mansoni 153 
and in H. polygyrus [28,50]. Secretion of exosomes from the cuticle surface in parasitic 154 
nematodes has yet to be documented although exosomes released by C. elegans epithelial 155 
cells are more likely to contribute to formation of the overlaying cuticle rather than be 156 
secreted into the extracellular environment from the worm surface [22].  157 
Transmission electron microscopy has revealed the presence of structures within the 158 
tegumental syncytium of parasitic trematodes that resemble the MVBs observed in 159 
mammalian cells (Figure 1) [4,32,51]. These structures have been shown to fuse with the 160 
apical plasma membrane at the tegumental surface from where vesicles, compatible in size 161 
with exosomes, are discharged [51]. These observations, and the fact that trematode 162 
exosomes contain a considerable number of tegumental-associated proteins [47], suggest a 163 
role for the tegument in exosome secretion. It is noteworthy, given the multitude of 164 
ultrastructural studies performed on F. hepatica and other trematodes, that these putative 165 
MVBs have not been described more widely in the literature. Wilson et al. [4] reported the 166 
appearance of MVB-like structures within the F. hepatica tegumental syncytium in response 167 
to culturing the flukes in vitro which could suggest that some helminth EVs are released in 168 
response to stress. Indeed, the transient nature of MVB formation and exosome release makes 169 
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the phenomenon difficult to observe (even in mammalian cells) [18], but it could also 170 
indicate that alternative mechanisms of EV release are in operation in the parasite. 171 
 172 
Are there novel EV biogenesis pathways in helminths? 173 
Several studies have suggested the existence of atypical EV biogenesis pathways that 174 
combine elements of the ESCRT, lipid and tetraspanin pathways in mammalian cells [18]. 175 
Whilst the proteomics data largely supports an ESCRT-dependent origin for the exosome-like 176 
EVs released by F. hepatica, we also identified some components of ESCRT-independent 177 
pathways, such as sphingomyelinase and various members of the tetraspanin family, in its 178 
secretome [47]. Whilst this may be due to the presence of several sub-populations of EVs 179 
(either produced by distinct mechanisms or released from different parasite tissues), it could 180 
also indicate the coordinated participation of proteins from ESCRT-dependent and -181 
independent pathways in the production of exosome-like vesicles in F. hepatica, as has been 182 
described in other cell types [52]. In contrast, the larger Fasciola EVs were shown to be 183 
specifically enriched with the inactive 37 kDa cathepsin L zymogen and may originate from 184 
the specialised secretory cells that line the parasite gastrodermus [47]. Our preliminary 185 
biochemical characterisation of these EVs suggest they are distinct from the smaller 186 
exosome-like vesicles with respect to their cargo molecules. Data pertaining to their 187 
mechanism of biogenesis is currently lacking, although MVBs have not been described in the 188 
parasite gastrodermal cells. One possibility is the breakdown of the long finger-like 189 
membrane-bound lamellae, which extend from the gastrodermal cells into the gut lumen, to 190 
release free EVs. A similar mechanism has been described in the protozoan parasite, 191 
Trypanosoma brucei rhodesiense. These single-celled parasites produce membrane-bound 192 
nanotubes that extend up to 20 µm from the cell that disassociate into free EVs of around 80 193 
nm in diameter [53]. Further proteomics analysis of the gastrodermal cell-derived EVs and 194 
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subsequent immunolocalisation studies are required to investigate this possibility in fluke and 195 
other helminths.  196 
 197 
Are drug-induced “blebs” functionally equivalent to microvesicles? 198 
The appearance of membrane-bound “blebs” on the parasite surface is a common initial 199 
response to drug-induced stress that has been observed in various flatworm and roundworm 200 
parasites [54-56]. Blebs appear as vesicular structures that eventually pinch off from the 201 
plasma membrane bounding the parasite surface and have been best described by scanning 202 
electron microscopy studies of the trematode tegument. The released blebs are variable in 203 
size, usually ranging between 200 nm and a few micrometres, but can be more than 20 µm in 204 
diameter. Complementary transmission electron microscopy studies have confirmed that the 205 
blebs pinch directly from the tegumental surface and are released into the extracellular 206 
environment (Figure 2) [55,57-59]. It has been suggested that blebbing is an attempt by 207 
helminths to replenish tegument that has been lost or damaged due to drug action [60] or 208 
humoral immune challenge [61]. Given the abundance of pumps such as P-glycoprotein 1 in 209 
the parasite EV membrane [47] it is possible that blebs sequester anthelmintics before their 210 
release; thus, reducing their effective local concentration in the parasite tissues. Indeed, P-211 
glycoprotein reversal agents have been shown to increase the efficacy of triclabendazole 212 
(TCBZ) against TCBZ-resistant F. hepatica [62].   213 
The mechanism of bleb formation in helminths has yet to be determined, but it is 214 
thought to be a calcium-dependent process [63,64]. MVs also bud directly from the plasma 215 
membrane in response to raised intracellular Ca2+ levels [65]. Given these biochemical and 216 
structural similarities, it is conceivable that parasite blebs are formed using the same 217 
molecular machinery as the MVs released by mammalian cells; i.e. Ca2+-dependent 218 
cytoskeleton-driven remodelling of the plasma membrane. Transcriptomics and proteomics 219 
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analysis indicates that the major players in this process (including ARF6 GTPase, pivotal in 220 
MV biogenesis in mammalian cells) are conserved in F. hepatica although functional studies, 221 
such as RNAi, are needed to confirm their role in MV/bleb formation [47].  222 
 223 
Concluding remarks 224 
The discovery of parasite-derived EVs has changed our view of the host-parasite interface. 225 
The formation of EVs enables the parasite to release a range of effector molecules (including 226 
degradation-susceptible protein and RNA species) in a protected manner to ensure their safe 227 
delivery to host cells. The cargo of helminth exosome-like EVs contain numerous 228 
immunomodulatory proteins and microRNAs that alter host immune cell phenotype to 229 
support parasite survival and reproduction [28,33,47]. Additionally, helminth blebs/MVs 230 
likely represent a vital membrane repair mechanism in response to drug-induced damage or 231 
host antibody attack. If the molecular machinery responsible for either of these EV biogenesis 232 
pathways could be disrupted using selective inhibitors/blocking antibodies, it might just be 233 
possible to tip the host immune balance in favour of parasite elimination; by preventing 234 
immune suppression by EV-delivered parasite immunomodulators or to enhance the potency 235 
of existing anthelmintic drugs by impairing parasite membrane repair mechanisms. Whilst 236 
recent proteomics and functional studies have considerably advanced our understanding of 237 
parasite EVs, many basic research questions remain (see Outstanding Questions). By 238 
addressing these areas, we may have a realistic chance of targeting EVs to achieve parasite 239 
control in the future.  240 
 241 
Glossary 242 
 Bleb: a blister-like protrusion of the plasma membrane on the cell surface. 243 
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 Endosomal sorting complex required for transport (ESCRT): a series of up to 30 244 
membrane-associated proteins that interact directly to form distinct molecular 245 
machineries that drive recruitment of cargo molecules, inward budding and abscission 246 
of the endosomal membrane during ILV or MVB formation.  247 
 Extracellular vesicle: small membrane-bound vesicles shed from most viable cell 248 
types. Includes exosomes (30-100 nm in diameter) that are formed from the 249 
endosomal pathway and microvesicles (100-1000 nm in diameter) that pinch directly 250 
from the plasma membrane. 251 
 Multivesicular body (MVB): a mature endosome that contains numerous vesicles 252 
(termed intra-luminal vesicles; ILVs) within their interior. They are formed by 253 
inward budding of the endosomal membrane followed by abscission of the ILV into 254 
the endosome lumen. 255 
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Figure 1. Biogenesis of exosome-like extracellular vesicles in the tegument of 481 
trematodes. 482 
(A) Schematic representation of the proposed exosome biogenesis pathway in the trematode 483 
tegument and the major components likely involved based upon mass spectrometry analysis 484 
of secreted exosome-like extracellular vesicles (EVs). Endosomal sorting complexes required 485 
for transport (ESCRT)-dependent (TSG101, ALIX and VPS4) and –independent (aSMase 486 
and CD63 tetraspanin) components may contribute to the initial formation of multivesicular 487 
bodies (MVBs), which are directed towards the apical plasma membrane (APM) of the 488 
tegumental syncytium. Here, soluble N-ethylmaleimide-sensitive factor activating protein 489 
receptor (SNAREs) (such as syntaxin, SNAP-25 and VAMP7) together with small GTPases 490 
(including Rab11, Rab27 and Ral-A) may facilitate the tethering and fusion of the MVB to 491 
the plasma membrane allowing the release of parasite-derived exosomes into the host 492 
microenvironment. S, spine. (B) Transmission electron micrograph of the tegumental 493 
syncytium of adult Fasciola hepatica containing structures that resemble MVBs. Inset, 494 
magnification of a MVB-like structure containing several intraluminal vesicles (ILVs). 495 
aSMase, acid sphingomyelinase. 496 
 497 
Figure 2. Microvesicle/bleb release from the apical plasma membrane of the trematode 498 
tegument. 499 
(A) Schematic representation of the proposed mechanism of bleb/microvesicle (MV) 500 
formation and release from the apical plasma membrane (APM) of the trematode tegument. 501 
An increase in intracellular Ca2+ concentration triggers a signalling cascade that promotes the 502 
excision of MVs/blebs directly from the tegmental surface. This “budding” process requires a 503 
state of membrane asymmetry, conducted by phospholipid translocases (e.g. scramblase), 504 
which is driven further by calpain-dependent cleavage and rearrangement of the actin 505 
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cytoskeleton. The actin-binding proteins ezrin, radixin and moesin (ERM) are also involved 506 
in the reassembly of the cytoskeleton following MV/bleb formation. S, spine. (B) Scanning 507 
electron micrograph of the surface of the Fasciola hepatica tegument showing profuse 508 
blebbing. (C) Transmission electron micrograph of F. hepatica tegumental syncytium 509 
showing the pinching of blebs/MVs from the apical plasma membrane and their release from 510 
the tegumental surface. Arrowheads; MV/blebs.  511 
 512 
 513 
 514 
 515 
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Table 1. Key regulators of EV biogenesis in mammalian cells and their orthologues in helminths 
Protein Function EV subtype RNAi phenotype in 
mammalian cells 
Present in 
Helminth EVs 
RNAi phenotypes of 
C. elegans orthologues 
Refs 
HRS/HGS ESCRT-0 component Exo EV secretion ↓ - Gro, Dpy, Unc [36] 
STAM ESCRT-0 component Exo EV secretion ↓ - Emb, Lva, Let, Ste, Gro, Stp [36] 
TSG101 ESCRT-I component Exo & MV EV secretion ↓ Fhd Emb, Lva, Let, Ste, Gro, Stp [36,37] 
VPS22/SNF8 ESCRT-II component Exo EV secretion ↓ - Emb, Lva, Let, Ste, Gro, Stp [37] 
CHMP2A ESCRT-III component Exo EV secretion ↓ Fh Emb, Lva, Let, Ste, Gro, Stp [37] 
CHMP4 ESCRT-III component Exo EV secretion ↑↓ - Emb, Let, Bmd, Prl [36,37] 
VPS4 EV abscission Exo & MV EV secretion ↑↓ Fh, Sm Emb, Let, Unc, Prl, Gro [36,37] 
ALIX/PDCD6IP ILV formation/cargo sorting Exo EV secretion ↓ Fh, Sm, Dd, Hp Emb, Lva, Let, Ste, Gro, Stp [36,37] 
Syndecan ILV formation/cargo sorting Exo EV secretion ↓ - Let [37] 
Syntenin ILV formation/cargo sorting Exo EV secretion ↓ Fh, Ov, Sm - [37] 
Sphingomyelinase Ceramide-dependent ILV 
formation 
Exo & MV EV secretion ↓ b Fh Emb, Lva, Let, Ste, Gro, Stp [17,38] 
CD63 antigen ILV formation/cargo sorting Exo No effect Fh, Ov, Sm, Sj - [37] 
Rab27 Fusion of MVB with the PM Exo EV secretion ↓ Fh Emb, Lva, Let, Ste, Gro, Stp [21] 
Rab35 Fusion of MVB with the PM Exo EV secretion ↓ Fh Let [39] 
Rab11 Fusion of MVB with the PM Exo EV secretion ↓ Fh, Sm, Sj, Hp Emb, Lva, Let, Ste, Gro, Stp [40,41] 
Ral-1/Ral-A Fusion of MVB with the PM Exo EV secretion ↓ Fh, Hp Let [22] 
Syntaxin Q-SNARE Exo EV secretion ↓ Fh, Sm Let [42] 
SNAP-25 T-SNARE Exo ND Fh, Sm Emb, Lva, Let, Ste, Gro, Stp [8] 
YKT6 R-SNARE Exo EV secretion ↓ - Clr, Emb, Sck, Gro, Stp [43] 
Phospholipid 
translocases a 
PM curvature  MV ND Fh Emb, Lva, Let, Ste, Gro, Stp, 
Spn 
[25] 
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Calpain Cytoskeletal remodelling MV ND Fh, Ov, Sm Emb, Lva, Let, Ste, Gro, Stp [25] 
Phospholipases Signal-induced cytoskeletal 
regulation  
Exo & MV EV secretion ↓ Fh Emb, Lva, Let, Ste, Gro, Stp [44] 
ARF6 Reorganization of the actin 
cytoskeleton 
Exo & MV EV secretion ↓ Fh, Sj Emb, Lva, Let, Ste, Gro, Stp [44] 
vATPase (V0) Fusion of MVB with the PM Exo MVB accumulation c Fh, Sj, Hp, Bm Clr, Emb, Sck, Gro, Stp [45] 
a flippases, floppases and scramblases; b phenotype observed using chemical inhibitors; c in C. elegans. dAbbreviations: Fh, Fasciola hepatica; Ov, Opisthorchis viverrini; Sm, 
Schistosoma mansoni; Sj, Schistosoma japonicum; Dd, Dicrocelium dendriticum; Hp, Heligsomoides polygyrus; Bm, Brugia malayi; PM, plasma membrane; Exo, exosome, 
MV, microvesicle. Ste, sterile; Lva, larval arrest; Emb, embryonic lethal; Gro, slow growth; Unc, locomotion abnormal; Dpy, dumpy; Clr, clear; Stp, sterile progeny; Bmd, 
organism morphology abnormal; Let, larval lethal; Prl, paralysed; Sck, sick; Spn, Abnormal spindle orientation; ND, not determined.  
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Trends 
 Parasite-derived EVs are now recognised as important mediators of molecular 
communication between host and parasite. 
 Transcriptomics and proteomics profiling has identified a range of 
immunomodulatory cargo molecules packaged into these but has also begun to shed 
light on the mechanisms used by helminths to generate and release EVs into the host 
microenvironment. 
 Although technically challenging, selective inhibition of parasite EV biogenesis 
pathways would prevent the delivery of a range of immunomodulators to host cells 
and tip the immune balance in favour of parasite elimination. 
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Outstanding questions 
 What mechanisms/pathways are used by helminths to produce and export EVs? 
 Are these pathways novel or distinct from those used by mammalian cells? 
 Are helminth EVs secreted constitutively or in response to stress? 
 Do drug-induced MVs/blebs contribute to mechanisms of drug resistance in parasites? 
 Are parasite-derived EVs essential for survival in the mammalian host?  
 Can selective inhibitors of key “checkpoints” in parasite EV biogenesis pathways be 
developed? 
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